These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 1986287)

  • 1. Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial.
    Ellis CN; Fradin MS; Messana JM; Brown MD; Siegel MT; Hartley AH; Rocher LL; Wheeler S; Hamilton TA; Parish TG
    N Engl J Med; 1991 Jan; 324(5):277-84. PubMed ID: 1986287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of remission during maintenance cyclosporine therapy for psoriasis. Relationship to maintenance dose and degree of improvement during initial therapy.
    Ellis CN; Fradin MS; Hamilton TA; Voorhees JJ
    Arch Dermatol; 1995 Jul; 131(7):791-5. PubMed ID: 7611794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term changes in renal function, blood pressure, and electrolyte levels in patients receiving cyclosporine for dermatologic disorders.
    Gupta AK; Rocher LL; Schmaltz SP; Goldfarb MT; Brown MD; Ellis CN; Voorhees JJ
    Arch Intern Med; 1991 Feb; 151(2):356-62. PubMed ID: 1992963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis.
    Heydendael VM; Spuls PI; Opmeer BC; de Borgie CA; Reitsma JB; Goldschmidt WF; Bossuyt PM; Bos JD; de Rie MA
    N Engl J Med; 2003 Aug; 349(7):658-65. PubMed ID: 12917302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of cyclosporin treatment of severe, chronic psoriasis vulgaris].
    Engst R; Huber J
    Hautarzt; 1989 Aug; 40(8):486-9. PubMed ID: 2676910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group.
    Tugwell P; Pincus T; Yocum D; Stein M; Gluck O; Kraag G; McKendry R; Tesser J; Baker P; Wells G
    N Engl J Med; 1995 Jul; 333(3):137-41. PubMed ID: 7791814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of topical cyclosporine rinse on oral lichen planus. A double-blind analysis.
    Eisen D; Ellis CN; Duell EA; Griffiths CE; Voorhees JJ
    N Engl J Med; 1990 Aug; 323(5):290-4. PubMed ID: 2195345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease.
    Brynskov J; Freund L; Rasmussen SN; Lauritsen K; de Muckadell OS; Williams N; MacDonald AS; Tanton R; Molina F; Campanini MC
    N Engl J Med; 1989 Sep; 321(13):845-50. PubMed ID: 2671739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine in the treatment of palmoplantar pustulosis. A randomized, double-blind, placebo-controlled study.
    Reitamo S; Erkko P; Remitz A; Lauerma AI; Montonen O; Harjula K
    Arch Dermatol; 1993 Oct; 129(10):1273-9. PubMed ID: 8215491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity Index score (improvement of 75% or greater) at 12 weeks.
    Sivanesan SP; Gattu S; Hong J; Chavez-Frazier A; Bandow GD; Malick F; Kricorian G; Koo J
    J Am Acad Dermatol; 2009 Nov; 61(5):793-8. PubMed ID: 19766350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction.
    Papp KA; Tyring S; Lahfa M; Prinz J; Griffiths CE; Nakanishi AM; Zitnik R; van de Kerkhof PC; Melvin L;
    Br J Dermatol; 2005 Jun; 152(6):1304-12. PubMed ID: 15948997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose cyclosporine A in severe psoriasis.
    Marks J
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):68-71. PubMed ID: 3381305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: a 2-year cohort study.
    Ho VC; Griffiths CE; Berth-Jones J; Papp KA; Vanaclocha F; Dauden E; Beard A; Puvanarajan L; Paul C
    J Am Acad Dermatol; 2001 Apr; 44(4):643-51. PubMed ID: 11260540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etanercept treatment for children and adolescents with plaque psoriasis.
    Paller AS; Siegfried EC; Langley RG; Gottlieb AB; Pariser D; Landells I; Hebert AA; Eichenfield LF; Patel V; Creamer K; Jahreis A;
    N Engl J Med; 2008 Jan; 358(3):241-51. PubMed ID: 18199863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial.
    Feldman SR; Gordon KB; Bala M; Evans R; Li S; Dooley LT; Guzzo C; Patel K; Menter A; Gottlieb AB
    Br J Dermatol; 2005 May; 152(5):954-60. PubMed ID: 15888152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trial.
    Gottlieb AB; Evans R; Li S; Dooley LT; Guzzo CA; Baker D; Bala M; Marano CW; Menter A
    J Am Acad Dermatol; 2004 Oct; 51(4):534-42. PubMed ID: 15389187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine improves psoriasis in a double-blind study.
    Ellis CN; Gorsulowsky DC; Hamilton TA; Billings JK; Brown MD; Headington JT; Cooper KD; Baadsgaard O; Duell EA; Annesley TM
    JAMA; 1986 Dec; 256(22):3110-6. PubMed ID: 3023712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension.
    van de Kerkhof PC; Segaert S; Lahfa M; Luger TA; Karolyi Z; Kaszuba A; Leigheb G; Camacho FM; Forsea D; Zang C; Boussuge MP; Paolozzi L; Wajdula J
    Br J Dermatol; 2008 Nov; 159(5):1177-85. PubMed ID: 18673365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy.
    Prummel MF; Mourits MP; Berghout A; Krenning EP; van der Gaag R; Koornneef L; Wiersinga WM
    N Engl J Med; 1989 Nov; 321(20):1353-9. PubMed ID: 2519530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases.
    Feutren G; Mihatsch MJ
    N Engl J Med; 1992 Jun; 326(25):1654-60. PubMed ID: 1588978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.